Standard Chemical & Pharmaceutical Co. Ltd. (TPE:1720)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
58.60
+0.40 (0.69%)
May 29, 2025, 1:30 PM CST
-15.68%
Market Cap 10.47B
Revenue (ttm) 6.82B
Net Income (ttm) 822.47M
Shares Out 178.70M
EPS (ttm) 4.60
PE Ratio 12.74
Forward PE n/a
Dividend 2.80 (4.78%)
Ex-Dividend Date Aug 1, 2024
Volume 84,707
Average Volume 148,547
Open 58.60
Previous Close 58.20
Day's Range 58.10 - 58.60
52-Week Range 51.20 - 79.40
Beta 0.07
RSI 49.17
Earnings Date May 7, 2025

About TPE:1720

Standard Chemical & Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, supplements, and APIs in Taiwan and internationally. The company offers various pharmaceutical products for metabolic, respiratory, musculoskeletal, digestive, circulatory system, topical dermatological, cardiovascular system, anti-infectives, urogenital system and sex hormones, and others. It engages in processing, manufacturing, and selling of food; and offers western medicine, nourishment, and function food, biochemical nutrition, and ... [Read more]

Sector Healthcare
Founded 1967
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1720
Full Company Profile

Financial Performance

In 2024, TPE:1720's revenue was 6.79 billion, an increase of 8.81% compared to the previous year's 6.24 billion. Earnings were 880.50 million, an increase of 5.46%.

Financial Statements

News

There is no news available yet.